You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fluorocholine (FCH)

Showing 1 - 25 of 52
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

18F-fluorocholine, Positron-Emission Tomography, Hyperparathyroidism, Primary Trial in Toronto ([F-18]-FCH PET/MRI)

Active, not recruiting
  • 18F-fluorocholine
  • +2 more
  • [F-18]-FCH PET/MRI
  • Toronto, Ont, Canada
    UHN
Dec 9, 2022

Multiple Myeloma Trial in Besançon, Dijon (FDG and FCH PET/CT)

Recruiting
  • Multiple Myeloma
  • FDG and FCH PET/CT
  • Besançon, France
  • +2 more
Mar 24, 2022

Fluorocholine PET/CT Trial (18F-fluorocholine PET/CT.)

Not yet recruiting
  • Fluorocholine PET/CT
  • 18F-fluorocholine PET/CT.
  • (no location specified)
Oct 24, 2022

Hepatocellular Carcinoma Non-resectable Trial in Honolulu (Fluorine-18 fluorocholine)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Fluorine-18 fluorocholine
  • Honolulu, Hawaii
    The Queen's Medical Center
Mar 28, 2022

Brain Metastases Trial in New York (18F-FCH PET Scan)

Completed
  • Brain Metastases
  • 18F-FCH PET Scan
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 15, 2022

Hyperparathyroidism, Parathyroid Adenoma Trial (We assessed sensitivity of 18F-FCH PET/CT in preoperative localisation of

Completed
  • Hyperparathyroidism
  • Parathyroid Adenoma
  • We assessed sensitivity of 18F-FCH PET/CT in preoperative localisation of hyperfunctioning parathyroid tissue in patients with primary hyperparathyroidism
  • (no location specified)
Sep 25, 2020

Patients Eligible to a Curative Treatment for Primary HCC Trial in La Tronche, Lyon, Pierre-Bénite (PET/MRI system (SIEMENS AG,

Recruiting
  • Patients Eligible to a Curative Treatment for Primary HCC
  • PET/MRI system (SIEMENS AG, Munich, Germany; distributed in France by SIEMENS S.A.S, Saint-Denis, France)
  • La Tronche, France
  • +3 more
Jan 12, 2021

Parathyroid Adenoma Trial (18Fluorocholine)

Not yet recruiting
  • Parathyroid Adenoma
  • (no location specified)
May 26, 2023

Prostate Cancer Trial in Australia, Canada, United Kingdom (18F-FCH PET/MRI Scan)

Completed
  • Prostate Cancer
  • 18F-FCH PET/MRI Scan
  • Sydney, New South Wales, Australia
  • +9 more
Apr 4, 2022

Carcinoma, Hepatocellular Trial in Dijon (FDG Positron Emission Tomography, FCH Positron Emission Tomography)

Unknown status
  • Carcinoma, Hepatocellular
  • FDG Positron Emission Tomography
  • FCH Positron Emission Tomography
  • Dijon, France
    Emilie REDERSTORFF
Mar 14, 2019

Hyperparathyroidism, Primary Trial in San Francisco (18F-Fluorocholine, Positron emission tomography (PET))

Recruiting
  • Hyperparathyroidism, Primary
  • San Francisco, California
    University of California, San Francisco
Aug 17, 2021

Myeloma Multiple Trial in Pessac (Positron Emission Tomography using 18F-FCH, Positron Emission Tomography using 18F-FDG)

Recruiting
  • Myeloma Multiple
  • Positron Emission Tomography using 18F-FCH
  • Positron Emission Tomography using 18F-FDG
  • Pessac, France
    Bordeaux University Hospital - Haut-Lévêque
Mar 30, 2022

F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in

Completed
  • Prostate Cancer
    • Lausanne, CH, Switzerland
      Centre Hospitalier Universitaire Vaudois
    Jul 22, 2021

    Parathyroid Diseases Trial in Taipei (18F-choline PET)

    Completed
    • Parathyroid Diseases
    • 18F-choline PET
    • Taipei, Taiwan
      National Taiwan Univeristy Hospital
    Jun 25, 2019

    Prostate Cancer Trial in Tripler AMC (Fluourine-18 Fluoromethylcholine PET/CT Imaging)

    Completed
    • Prostate Cancer
    • Fluourine-18 Fluoromethylcholine PET/CT Imaging
    • Tripler AMC, Hawaii
      Tripler Army Medical Center
    Jul 19, 2022

    Prostate Cancer Trial in Hamilton, London, Toronto ([F-18]-FCH, PET scan, MRI scan)

    Terminated
    • Prostate Cancer
    • [F-18]-FCH
    • +2 more
    • Hamilton, Ontario, Canada
    • +2 more
    May 3, 2019

    Prostate Cancer Trial in London (Imaging Panel)

    Active, not recruiting
    • Prostate Cancer
    • Imaging Panel
    • London, Ontario, Canada
      London Health Sciences Centre
    Dec 14, 2021

    Prostate Cancer Recurrent Trial in Saint-Beauzire (DCFPyL)

    Unknown status
    • Prostate Cancer Recurrent
    • DCFPyL
    • Saint-Beauzire, France
      CURIUM PET France
    Feb 1, 2021

    Prostate Cancer, Fluorocholine Trial in Hualien (18F-fluorocholine)

    Completed
    • Prostate Cancer
    • Fluorocholine
    • Hualien, Taiwan
      Hualien Tzu Chi Hospital
    Apr 9, 2020

    Hyperparathyroidism Trial in Hualien (18F-fluorocholine PET/CT)

    Completed
    • Hyperparathyroidism
    • 18F-fluorocholine PET/CT
    • Hualien, Taiwan
      Hualien Tzu Chi Hospital
    Mar 18, 2020

    Prostate Cancer Trial in San Francisco (Carbon C 11 Choline, Fluorine F 18 Choline, Positron Emission Tomography (PET) /

    Completed
    Has Results
    • Prostate Cancer
    • Carbon C 11 Choline
    • +2 more
    • San Francisco, California
      University of California San Francisco
    Oct 27, 2020

    Prostate Cancer Trial in Vandoeuvre Les Nancy (68Ga-PSMA-11 PET, 18F-FCH PET)

    Unknown status
    • Prostate Cancer
    • 68Ga-PSMA-11 PET
    • 18F-FCH PET
    • Vandoeuvre Les Nancy, France
      CHRU de NANCY- BRABOIS
    Aug 6, 2018

    An Imaging Study of FCH-PET-CT in Prostate Cancer andBRCA Gene

    Recruiting
    • Prostate Cancer
    • +2 more
    • MRI pelvis or CT imaging
    • +2 more
    • London, Sutton, Surrey, United Kingdom
      Cancer Genetics Unit, Royal Marsden Hospital
    Mar 30, 2022

    Hyperparathyroidism, Primary Trial in San Francisco (18F-Fluorocholine, Positron Emission Tomography (PET))

    Completed
    Has Results
    • Hyperparathyroidism, Primary
    • San Francisco, California
      University of California, San Francisco
    Sep 21, 2021

    Prostate Cancer, Prostate Cancer Recurrent Trial in France (F-18-PSMA-1007, F-18-Fluorocholine)

    Completed
    • Prostate Cancer
    • Prostate Cancer Recurrent
    • Clermont-Ferrand, France
    • +5 more
    Jun 28, 2021